Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pDONR223_RARA_WT_V5 Citations (1)

Originally described in: High-throughput Phenotyping of Lung Cancer Somatic Mutations.
Berger AH, Brooks AN, Wu X, Shrestha Y, Chouinard C, Piccioni F, Bagul M, Kamburov A, Imielinski M, Hogstrom L, Zhu C, Yang X, Pantel S, Sakai R, Watson J, Kaplan N, Campbell JD, Singh S, Root DE, Narayan R, Natoli T, Lahr DL, Tirosh I, Tamayo P, Getz G, Wong B, Doench J, Subramanian A, Golub TR, Meyerson M, Boehm JS Cancer Cell. 2016 Aug 8;30(2):214-28. doi: 10.1016/j.ccell.2016.06.022. Epub 2016 Jul 28.
PubMed Journal

Articles Citing pDONR223_RARA_WT_V5

Articles
Impact of RARalpha and miR-138 on retinoblastoma etoposide resistance. Busch M, Miroschnikov N, Dankert JT, Wiesehofer M, Metz K, Stephan H, Dunker N. Tumour Biol. 2021;43(1):11-26. doi: 10.3233/TUB-200072. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.